Your search for ‘McGuireWoods’ returned 3,654 results

In addition to the fine, NewDay agreed to stop paying kickbacks and engaging in deceptive marketing practices.

Last Thursday, December 4, 2014, the Consumer Financial Protection Bureau (CFPB) reached a settlement agreement with Premier Consulting Group LLC and the Law Office of Michael Lupoloverrequiring the defendants to pay a fine of roughly $69,000 for allegedly charging consumers illegal upfront fees for debt relief services.

On Feb. 16, 2010, the Small Business Administration's Investment Division announced the completion of revisions to the Management Assessment Questionnaire (MAQ), the initial gating document for fund managers seeking to form a Small Business Investment Company (SBIC Fund).

Blue Heron Capital has closed out its latest fund with $102 million, according to industry reports. The new fund, Blue Heron Capital Fund III, was oversubscribed.

Clarus Ventures has set out to raise $375 million for a new life sciences VC fund.

In a report authored by CMS's Office of the Actuary and published in Health Affairs, CMS projected that healthcare spending would grow by an average of 5.8% in the aggregate over 2014-2024.

Dr. Margaret Hamburg, Food and Drug Administration Commissioner, has urged officials from all 50 states to close regulatory loopholes involving the safety of compounding drugs and to issue new regulations to head off future public health disasters.

Earlier this week, Judge Henry Hudson of the United States District Court for the Eastern District of Virginia became the first judge to strike down as unconstitutional the Minimum Essential Coverage Provision of the healthcare reform law, which requires uninsured individuals to carry certain levels of health insurance.

Andrew Alliance has announced the closing of a series B financing round.

CAS Medical Systems (CASMED) announced in late June that it entered into a $10 million loan agreement with General Electric Capital Corp.

Johnson & Johnson has announced it has accepted a $4 billion binding offer from PE firm Carlyle Group for its Ortho Clinical Diagnostics business.

Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies.

Quest Diagnostics has announced it has entered into a definitive agreement to acquire Solstas Lab Partners Group and its subsidiaries for approximately $570 million.

Surge Private Equity has announced it has invested in Elite Clinical Network (ECN) in a transaction valued at around $200 million.

The legislation passed by a vote of 392-37 with 212 Republicans and 180 Democrats supporting the proposal.

Meridian Surgical Partners, a national operator of outpatient ambulatory surgery centers, announced on September 10 that it had settled a qui tam lawsuit.

Health Diagnostic Laboratory in Virginia and several other labs are under investigation by the Office of Inspector General and Justice Department.